A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use

Pediatric Surgery International

Volumn 28, Issue 11, 2012, Pages 1059-1069

  Basta, Marten N ^a   Stricker, Paul A ^b   Taylor, Jesse A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

6 Aminocaproic acid; Amicar; Aminocaproic acid; Antifibrinolytic; Aprotinin; Child; Cyklokapron; EACA; Pediatric; Tranexamic acid; Trasylol; TXA

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; TRANEXAMIC ACID;

BLEEDING; BLOOD TRANSFUSION; COCHRANE LIBRARY; CRANIOFACIAL SURGERY; DRUG EFFICACY; DRUG SAFETY; EMBASE; HUMAN; MEDLINE; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

6-AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CHILD; CRANIOTOMY; FACE; HEMOSTATICS; HUMANS; SPINE; TRANEXAMIC ACID;

EID: 84871422870     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-012-3167-6     Document Type: Review

References (46)

1. Guay J, Rivard GE (1996) Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann ThoracSurg 62:1955-1960
2. Williams GD, Bratton SL, Ramamoorthy C (1999) Factors associated with blood loss and blood product transfusions: A multivariate analysis in children after open-heart surgery. Anesth Analg 89:57-64
3. Chan AK, Leaker M, Burrows FA et al (1997) Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 77:270-277
4. Meert KL, Kannan S, Mooney JF (2002) Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine 27:2137-2142
5. Meyer P, Renier D, Arnaud E et al (1993) Blood loss during repair of craniosynostosis. Br J Anaesth 71:854-857
6. Feldman JM, Roth JV, Bjoraker DG (1995) Maximum blood savings by acute normovolemic hemodilution. Anesth Analg 80:108-113
7. Chauhan S, Kumar BA, Rao BH et al (2000) Efficacy of aprotinin, epsilon aminocaproic acid or combination in cyanotic heart disease. Ann Thorac Surg 70:1308-1312
8. Florentino-Pineda I, Thompson GH, Poe-Kochert C et al (2004) The effect of amicar on perioperative blood loss in idiopathic scoliosis: The results of a prospective, randomized, double-blind study. Spine 29:233-238
9. Goobie SM, Meier PM, Pereira LM et al (2011) Efficacy of tranexamic acid in pediatric craniosynostosis surgery: A doubleblind Placebo-controlled trial. Anesthesiology 114:862-871
10. Dadure C, Sauter M, Bringuier S et al (2011) Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: A randomized double-blind study. Anesthesiology 114:856-861
11. Fergusson DA, Hebert PC, Mazer CD et al (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358(22):2319-2331
12. OCEBM Levels of Evidence Working Group Oxford Centre for Evidence-Based Medicine The Oxford 2011 levels of evidence. http://www.cebm.net/index.aspx?o= 5653. Accessed 19 Jan 2012 (OCEBM levels of evidence working group = Jeremy Howick, Iain Chalmers (James Lind Library), Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips, Hazel Thornton, Olive Goddard and Mary Hodgkinson) Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011
13. Rao BH, Saxena S, Chauhan S et al (2000) Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. Indian J Med Res 111:57-61
14. Williams GD, Bratton SL, Riley EC et al (1999) Efficacy of e-aminocaproic acid in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 13:304-308
15. Chauhan S, Bisoi A, Modi R et al (2003) Tranexamic acid in paediatric cardiac surgery. Indian J Med Res 118:86-89
16. Levin E, Wu J, Devine DV et al (2000) Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 83:54-59
17. Reid RW, Zimmerman A, Laussen PC et al (1997) The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 84:990-996
18. Zonis Z, Seear M, Reichert C et al (1996) The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 111:982-987
19. Carrel TP, Schwanda M, Vogt PR et al (1998) Aprotinin in pediatric cardiac operations: A benefit in complex malformations and with high dose regimen only. Ann Thorac Surg 66:153-158
20. Chiravuri SD, Voepel-Lewis T, Devaney EJ et al (2008) The use of aprotinin in children undergoing operative repair of isolated atrial septal defects. Pediatr Anesth 18:145-150
21. Costello JM, Backer CL, de Hoyos A et al (2003) Aprotinin reduces operative closure time and blood product use after pediatric bypass. Ann Thorac Surg 75:1261-1266
22. Davies MJ, Allen A, Kort H et al (1997) A prospective, randomized, double-blind study of high dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 63:497-503
23. D'Errico CC, Shayevitz JR, Martindale SJ et al (1996) Efficacy and cost of aprotinin in children undergoing operative open heart surgery. Pediatr Anesth 83:1193-1199
24. Herynkopf F, Lucchese F, Pereira E et al (1994) Aprotinin in children undergoing correction of congenital heart defects: A double-blind pilot study. J Thorac Cardiovasc Surg 108:517-521
25. Miller BE, Tosone SR, Tam VK et al (1998) Hematologic and economic impact of aprotinin in reoperative pediatric operations. Ann Thorac Surg 66:535-540
26. Mossinger H, Dietrich W, Braun SL et al (2003) High dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 75:430-437
27. Penkoske PA, Entwistle LM, Marchak BE et al (1995) Aprotinin in children undergoing repair of congenital heart defects. Ann Thorac Surg 60:529-532
28. Williams GD, Ramamoorthy C, Pentcheva K et al (2008) A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery. Pediatr Anesth 18:812-819
29. Chauhan S, Das SN, Bisoi A et al (2004) Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 18:141-143
30. Martin K, Gertler R, Sterner A et al. (2011) Comparison of bloodsparing efficacy of e-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery. J Thorac Cardiovasc Surg
31. Bulutcu FS, Ozbek U, Polat B et al (2005) Which may be effective to reduce blood loss after cardiac operations in cyanotic children: Tranexamic acid, aprotinin or a combination? Pediatr Anesth 15:41-46
32. D'Errico CC, Munro HM, Buchman SR et al (2003) Efficacy of aprotinin in children undergoing craniofacial surgery. J Neurosurg 99:287-290
33. Thompson GH, Florentino-Pineda I, Poe-Kochert C et al (2008) The role of amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. Spine 33:2237-2242
34. Thompson GH, Florentino-Pineda I, Poe-Kochert C et al (2008) Role of amicar in surgery for neuromuscular scoliosis. Spine 33:2623-2629
35. Florentino-Pineda I, Blakemore LC, Thompson GH et al (2001) The effect of e-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion. Spine 26:1147-1151
36. Grant JA, Howard J, Luntley J et al (2009) Perioperative blood transfusion requirements in pediatric scoliosis surgery: The efficacy of tranexamic acid. J Pediatr Orthop 29:300-304
37. Neilipovitz DT, Murto K, Hall L et al (2001) A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 93:82-87
38. Sethna NF, Zurakowski D, Brustowicz RM et al (2005) Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 102:727-732
39. Shapiro F, Zurakowski D, Sethna NF (2007) Tranexamic acid diminishes intraoperative blood loss and transfusion requirements in spinal fusions for duchenne muscular dystrophy scoliosis. Spine 32:2278-2283
40. Kasimian S, Skaggs DL, Sankar WN et al (2008) Aprotinin in pediatric neuromuscular scoliosis surgery. Eur Spine J 17:1671-1675
41. Khoshhal K, Mukhtar I, Clark P et al (2003) Efficacy of aprotinin in reducing blood loss in spinal fusion for idiopathic scoliosis. J Pediatr Orthop 23:661-664
42. Cole JW, Murray DJ, Snider RJ et al (2003) Aprotinin reduces blood loss during spinal surgery in children. Spine 28:2482-2485
43. Smith PK, Muhlbaier LH (1996) Aprotinin: Safe and effective only with the full dose regimen. Ann Thoracic Surg 62:1575-1577
44. Tzortzopoulou A, Cepeda MS (2008) Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children (review). Cochrane Libr 4:1-34
45. Schouten E, van de Pol AC, Schouten A et al (2009) The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A metaanalysis. Pediatr Crit Care Med 10:182-190
46. Carrier M, Denault A, Lavoie J, Perrault LP (2006) Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery. Ann Thorac Surg 82(1): 51-55